258 related articles for article (PubMed ID: 28477733)
1. Sex steroids and the GH axis: Implications for the management of hypopituitarism.
Birzniece V; Ho KKY
Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):59-69. PubMed ID: 28477733
[TBL] [Abstract][Full Text] [Related]
2. Modulation of growth hormone action by sex steroids.
Meinhardt UJ; Ho KK
Clin Endocrinol (Oxf); 2006 Oct; 65(4):413-22. PubMed ID: 16984231
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
[TBL] [Abstract][Full Text] [Related]
4. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
[TBL] [Abstract][Full Text] [Related]
5. Regulating of growth hormone sensitivity by sex steroids: implications for therapy.
Ho KKY; Gibney J; Johannsson G; Wolthers T
Front Horm Res; 2006; 35():115-128. PubMed ID: 16809927
[TBL] [Abstract][Full Text] [Related]
6. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty.
Mauras N; Rogol AD; Haymond MW; Veldhuis JD
Horm Res; 1996; 45(1-2):74-80. PubMed ID: 8742123
[TBL] [Abstract][Full Text] [Related]
7. [The influence of estrogen and progestogen replacement on growth hormone activity in women with hypopituitarism].
Isotton AL; Wender MC; Czepielewski MA
Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):901-16. PubMed ID: 18797598
[TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids.
Jørgensen JO; Christensen JJ; Krag M; Fisker S; Ovesen P; Christiansen JS
Horm Res; 2004; 62 Suppl 1():73-6. PubMed ID: 15761236
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement.
Veldhuis JD; Metzger DL; Martha PM; Mauras N; Kerrigan JR; Keenan B; Rogol AD; Pincus SM
J Clin Endocrinol Metab; 1997 Oct; 82(10):3414-20. PubMed ID: 9329378
[TBL] [Abstract][Full Text] [Related]
10. Growth hormones and sex steroid interactions at puberty.
Clark PA; Rogol AD
Endocrinol Metab Clin North Am; 1996 Sep; 25(3):665-81. PubMed ID: 8879992
[TBL] [Abstract][Full Text] [Related]
11. Administration route-dependent effects of estrogens on IGF-I levels during fixed GH replacement in women with hypopituitarism.
van der Klaauw AA; Biermasz NR; Zelissen PM; Pereira AM; Lentjes EG; Smit JW; van Thiel SW; Romijn JA; Roelfsema F
Eur J Endocrinol; 2007 Dec; 157(6):709-16. PubMed ID: 18057377
[TBL] [Abstract][Full Text] [Related]
12. Sex steroids and the growth hormone/insulin-like growth factor-I axis in adults.
Jørgensen JO; Christensen JJ; Vestergaard E; Fisker S; Ovesen P; Christiansen JS
Horm Res; 2005; 64 Suppl 2():37-40. PubMed ID: 16286769
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effect of raloxifene and estrogen on the metabolic action of growth hormone in hypopituitary women.
Birzniece V; Meinhardt U; Gibney J; Johannsson G; Baxter RC; Seibel MJ; Ho KK
J Clin Endocrinol Metab; 2010 May; 95(5):2099-106. PubMed ID: 20207825
[TBL] [Abstract][Full Text] [Related]
14. Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators.
Birzniece V; Sutanto S; Ho KK
J Clin Endocrinol Metab; 2012 Apr; 97(4):E521-7. PubMed ID: 22319035
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of raloxifene and estrogen on body composition in growth hormone-replaced hypopituitary women.
Birzniece V; Meinhardt UJ; Gibney J; Johannsson G; Armstrong N; Baxter RC; Ho KK
J Clin Endocrinol Metab; 2012 Mar; 97(3):1005-12. PubMed ID: 22170716
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine regulation of growth hormone and androgen axes by selective estrogen receptor modulators in healthy men.
Birzniece V; Sata A; Sutanto S; Ho KK
J Clin Endocrinol Metab; 2010 Dec; 95(12):5443-8. PubMed ID: 20843951
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of oestrogens: impact of the route of administration.
Ho KK; O'Sullivan AJ; Wolthers T; Leung KC
Ann Endocrinol (Paris); 2003 Apr; 64(2):170-7. PubMed ID: 12773957
[TBL] [Abstract][Full Text] [Related]
18. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents.
Coutant R; de Casson FB; Rouleau S; Douay O; Mathieu E; Gatelais F; Bouhours-Nouet N; Voinot C; Audran M; Limal JM
J Clin Endocrinol Metab; 2004 Dec; 89(12):6185-92. PubMed ID: 15579776
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone and estrogen: a clinician's approach.
Cook DM
J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1273-6. PubMed ID: 15506073
[TBL] [Abstract][Full Text] [Related]
20. Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women.
Wolthers T; Hoffman DM; Nugent AG; Duncan MW; Umpleby M; Ho KK
Am J Physiol Endocrinol Metab; 2001 Dec; 281(6):E1191-6. PubMed ID: 11701433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
